Searched for
CONCORD BIOTECH NEWS
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
- Stocks in news: DMart, SBI, Kotak Bank, M&M, Tejas NetworksPrivate lender Kotak Mahindra Bank reported its March quarter results for the financial year 2025, posting a 14% YoY dip in its standalone ...
- Stocks in news: BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord BiotechIn today's trade, shares of BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord Biotech among others will be in focus due to various news de...
- Concord Biotech shares tumble 16% after weak Q3 earningsConcord Biotech shares fell 16% to Rs 1,777.7 after the company reported a 2.1% YoY decline in Q3 FY25 net profit to Rs 75.92 crore, despit...
- These 4 stocks closed below VWAP on September 23we have compiled a list of six stocks that reached a 6-year
- Stocks in news: ZEE, Delhivery, Bandhan Bank, JSW Steel, Concord BiotechZEE Ltd has reported a net profit of Rs 13.35 crore for the quarter ended March 2024, compared with a loss of Rs 196 crore in the same quar...
- Concord Biotech shares list at 21% premium over IPO priceConcord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Stocks in news: Nykaa, HDFC AMC, Concord Biotech, JSW Steel, Adani EnergyNykaa, HDFC AMC, Indus Towers, Page Industries and ACC have been excluded from Nifty Next50 in the latest revision of various NSE indices.
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- Concord Biotech IPO: Issue subscribed 25 times on last day; check GMP and other detailsAnalysts advised investors to subscribe to the issue given its complex product portfolio, presence in niche space, strong client relationsh...
- SBFC Finance vs Concord Biotech: Which IPO should you pick?The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech i...
- Concord Biotech IPO subscribed 58% on Day OneThe non-institutional investors (NII) category was subscribed the most at 1.01 times, followed by retail investors at 72%. The category for...
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...
- Concord Biotech IPO: GMP indicates strong investors' interest ahead of issue openingAhead of the issue opening, the company's shares commanded a premium of Rs Rs 325 in the unlisted market
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
- Healthcare sector sees 88 funding deals worth $397 million in 2016According to News Corp VCCEdge Healthcare Sector Funding insights, out of the $ 397.41 mn deals so far this year, healthcare startups corne...
Load More
